Chemical formula: C₅₈H₆₆N₁₀O₉ Molecular mass: 1,047.206 g/mol PubChem compound: 9941444
Pasireotide is indicated for:
Population group: only adults (18 years old or older)
Treatment of adult patients with Cushing’s disease for whom surgery is not an option or for whom surgery has failed.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Treatment of adult patients with acromegaly for whom surgery is not an option or has not been curative and who are inadequately controlled on treatment with another somatostatin analogue.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Pasireotide is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
